BioWorld

June 17, 2002

Money Raised Year To Date

Stock Winners and Losers For The Week

Clinical Trial Update: May 2002

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: May 2002

FDA Submissions, Approvals And Other Actions: May 2002

Biotech Dream Of Going Global Attainable With Capital, Products

Every start-up biotech company dreams about breakthrough product approvals, positive cash flows and becoming global. (BioWorld Financial Watch) Read More

Today's news in brief

BioWorld

BioWorld briefs for June 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 4, 2025.

Regeneron boosts obesity pipeline with Hansoh’s GLP-1/GIP for $2B

BioWorld

Regeneron Pharmaceuticals Inc. is adding to its obesity pipeline by in-licensing Hansoh Biomedical Co. Ltd.’s phase III dual glucagon-like peptide 1...

Pharma execs speak out: UK pricing rebates scare investors

BioWorld

The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British Pharmaceutical Industry calling up its...

ASCO 2025: Verastem has positive cancer data but stock sags

BioWorld

New dose-escalation data from Verastem Oncology’s phase I/II cancer study in China prompted the company to say it was encouraged by the efficacy results. However,...